drugset / Trial / NCT02473601

Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis

NCT02473601

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Observed the muscle relaxation of mivacurium in patients with liver cirrhosis.Clear of mivacurium in patients with liver cirrhosis without muscle relaxant accumulation and delayed recovery phenomenon

Timeline

Start
2014-10
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Mivacurium Small molecule 6 mg/kg Intravenous

Indications